1. Home
  2. CZWI vs NGEN Comparison

CZWI vs NGEN Comparison

Compare CZWI & NGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citizens Community Bancorp Inc.

CZWI

Citizens Community Bancorp Inc.

HOLD

Current Price

$21.38

Market Cap

197.5M

Sector

Finance

ML Signal

HOLD

NGEN

NervGen Pharma Corp. Common stock

N/A

Current Price

$2.00

Market Cap

175.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CZWI
NGEN
Founded
1938
2017
Country
United States
Canada
Employees
N/A
9
Industry
Savings Institutions
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
197.5M
175.1M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
CZWI
NGEN
Price
$21.38
$2.00
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$18.00
AVG Volume (30 Days)
13.3K
1.1M
Earning Date
04-27-2026
04-02-2026
Dividend Yield
2.02%
N/A
EPS Growth
8.96
N/A
EPS
0.39
N/A
Revenue
N/A
N/A
Revenue This Year
$13.02
N/A
Revenue Next Year
$9.42
N/A
P/E Ratio
$51.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.15
$1.91
52 Week High
$22.62
$5.93

Technical Indicators

Market Signals
Indicator
CZWI
NGEN
Relative Strength Index (RSI) 62.16 23.23
Support Level $20.22 N/A
Resistance Level $21.75 $4.52
Average True Range (ATR) 0.57 0.16
MACD -0.01 -0.15
Stochastic Oscillator 68.55 4.35

Price Performance

Historical Comparison
CZWI
NGEN

About CZWI Citizens Community Bancorp Inc.

Citizens Community Bancorp Inc is a bank holding company that offers traditional community banking services to businesses, Agricultural operators, and consumers, including one-to-four-family residential mortgages. it also offers a variety of loan products including commercial real estate loans, commercial and industrial (C&I) loans, agricultural real estate loans, agricultural operating loans, residential mortgages, home equity lines-of-credit, and consumer loans and offers deposit products through its branches, including demand deposits, various savings and money-market accounts and certificates of deposit. The company's sources of funds are deposits; amortization, prepayments, and maturities of outstanding loans; other short - term investments; and funds provided from operations.

About NGEN NervGen Pharma Corp. Common stock

NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.

Share on Social Networks: